These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 332094)

  • 1. [Study of estrogenic effects of promestriene].
    Gaudefroy M; Pigache JP
    Arch Anat Cytol Pathol; 1977; 25(2):125-8. PubMed ID: 332094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hematocolpometra and local estrogen therapy: an overdose of promestriene?].
    Opinel P; Le Hors H; Tramier D; Inguimbert M; Audibert M; Cassin D
    J Gynecol Obstet Biol Reprod (Paris); 1991; 20(1):60-2. PubMed ID: 2019720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of the estrogenic potential of two synthetic estrogens (mestranol and ethinylestradiol).
    Teter J; Stupnicki R
    Acta Cytol; 1971; 15(2):167-70. PubMed ID: 5282948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Topical hormonal treatment and urogenital atrophy].
    Sitruk-Ware R; Thomas JL
    Praxis (Bern 1994); 1997 Aug; 86(33):1245-8. PubMed ID: 9381009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental studies of the estrogenic and anti-estrogenic effects of 17alpha-thiocyanomethyl-17beta-tetrahydropyranyloxyestra-1,3,5(10)-triene-3-methyl ether and 17beta-phenylaminocarbonylestra-1,3,5(10)-triene-3-methyl ether].
    Strecke J; Ivanenko T; Fedotow V; Schwetzow J
    Pharmazie; 1977 Oct; 32(10):598-602. PubMed ID: 607220
    [No Abstract]   [Full Text] [Related]  

  • 6. [Climacteric syndrome : clinical experiences using promestriene].
    Campana G; Di Grancesco
    Ann Ostet Ginecol Med Perinat; 1976; 97(3):189-97. PubMed ID: 797296
    [No Abstract]   [Full Text] [Related]  

  • 7. Absence of systemic hormonal effects in an oestradiol diether topically active on the vaginal mucosa.
    Wolff JP; Cachelou R; Guéritée N
    Maturitas; 1982 Dec; 4(4):239-46. PubMed ID: 7169959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vaginal cytological studies on the new delayed-action estrogen-ethinylestradiol sulfonate].
    Hempel E; Carol W; Klinger G; Rust J; Rust G
    Zentralbl Gynakol; 1975; 97(21):1281-6. PubMed ID: 1210860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potency of quinestrol as reflected by vaginal cytologic maturation.
    Hammond D
    Int J Fertil; 1967; 12(2):164-9. PubMed ID: 6033893
    [No Abstract]   [Full Text] [Related]  

  • 10. Estrogen effects on human oral epithelium. Cytologic, histologic and clinical comparisons.
    Silverman S; Shouse C
    J Oral Ther Pharmacol; 1966 Sep; 3(2):87-93. PubMed ID: 4291773
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experiences with a new non-steroid estrogen].
    Malato M; Arienzo R
    Rass Int Clin Ter; 1972 May; 52(10):620-7. PubMed ID: 4557793
    [No Abstract]   [Full Text] [Related]  

  • 12. Response of human vaginal epithelium to single high dose or daily lower dose of oral quinesteol.
    Bronstein SB; Stough A
    Int J Fertil; 1967; 12(2):170-5. PubMed ID: 5340516
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis and evaluation of B-, C-, and D-ring-substituted estradiol carboxylic acid esters as locally active estrogens.
    Labaree DC; Zhang JX; Harris HA; O'Connor C; Reynolds TY; Hochberg RB
    J Med Chem; 2003 May; 46(10):1886-904. PubMed ID: 12723952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment with low-dose vaginal estradiol in post-menopausal women. A double-blind controlled trial].
    Kjaergaard B; Walter S; Knudsen A; Johansen B; Barlebo H
    Ugeskr Laeger; 1990 Mar; 152(10):658-9. PubMed ID: 2181748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of raloxifene on the vaginal epithelium of postmenopausal women.
    Delmanto A; Nahas-Neto J; Nahas EA; de Oliveira ML; Fernandes CE; Traiman P
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):187-92. PubMed ID: 18400357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitive detection of the endocrine effects of the estrogen analogue ethinylestradiol using a modified enhanced subacute rat study protocol (OECD Test Guideline no. 407).
    Andrews P; Freyberger A; Hartmann E; Eiben R; Loof I; Schmidt U; Temerowski M; Folkerts A; Stahl B; Kayser M
    Arch Toxicol; 2002 May; 76(4):194-202. PubMed ID: 12029382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biologic action of promestriene on the genital tract of the castrated rat].
    Borrelli AL; Casolaro AM; Esposito G; Berlingieri D
    Minerva Ginecol; 1990 Nov; 42(11):467-72. PubMed ID: 2080035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in the vaginal mucosa in postmenopausal women during oral treatment with natural oestradiol and megestrolacetate.
    Gad C; Fischer S; Lebech PE; Wiese J
    Acta Obstet Gynecol Scand Suppl; 1971; 9():Suppl 9:27. PubMed ID: 5287099
    [No Abstract]   [Full Text] [Related]  

  • 19. [Estrogenic action of cardiac glycosides. Clinical and animal experiment studies].
    Hofmann P; Häffele R; Buchholz C
    Fortschr Med; 1975 Sep; 93(27):1274-6. PubMed ID: 1241381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women.
    Labrie F; Archer D; Bouchard C; Fortier M; Cusan L; Gomez JL; Girard G; Baron M; Ayotte N; Moreau M; Dubé R; Côté I; Labrie C; Lavoie L; Berger L; Gilbert L; Martel C; Balser J
    Menopause; 2009; 16(5):923-31. PubMed ID: 19424093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.